41 Stocks Moving In Monday's Mid-Day Session

Loading...
Loading...

Gainers

  • Dare Bioscience Inc DARE shares climbed 132.7% to $1.95 after the company announced an exclusive licensing agreement with Bayer for US commercial rights to Ovaprene. Dare will receive an upfront payment of $20 million and up to $310 million in milestones.
  • Mereo BioPharma Group plc MREO gained 37.2% to $2.88 after the company announced it has entered into a global licensing agreement with Oncologie for Navicixizumab. Mereo will receive an upfront payment of $4 million with an additional $2 million payment conditional on CMC milestone and up to $300 million in future milestones.
  • CounterPath Corporation CPAH shares rose 33% to $5.28 after climbing 304.12% on Friday.
  • Primo Water Corporation PRMW shares jumped 25% to $13.85 after the company agreed to be acquired by Cott Corp COT for $14 per share.
  • Verona Pharma plc VRNA rose 23.8% to $7.38. Verona Pharma reported primary endpoint met at all doses in 4 week Phase 2b COPD study with nebulized ensifentrine on top of tiotropium therapy.
  • Cardlytics Inc CDLX gained 20% to $81.78 after the company raised its Q4 sales guidance above analyst estimates.
  • Alphatec Holdings Inc ATEC gained 14% to $7.40.
  • BroadVision, Inc. BVSN climbed 13.4% to $2.80.
  • Ballard Power Systems Inc. BLDP rose 13.2% to $10.30 after gaining 5.59% on Friday.
  • Enlivex Therapeutics Ltd. ENLV rose 11.4% to $9.36.
  • Trillium Therapeutics Inc TRIL jumped 11% to $3.05 after the company raised FY2019 sales guidance.
  • MRI Interventions Inc MRIC gained 10.5% to $5.69. MRI Interventions obtained $17.5 million strategic investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management.
  • TerraForm Power Inc TERP gained 10.3% to $17.20 after the company confirmed the receipt of unsolicited proposal from Brookfield Renewable for 0.36 Brookfield Shares for each Terraform share owned.
  • Beyond Meat, Inc. BYND shares rose 10% to $105.58. Chinese plant-based meat substitute founder Vince Lu said entrance of Beyond Meat, Impossible Foods to China can raise the exposure of plant-based foods in the country.
  • Venator Materials PLC VNTR gained 9.9% to $3.57.
  • CareDx Inc CDNA gained 9.5% to $21.69 after the company raised FY2019 sales guidance.
  • OncoCyte Corp OCX rose 7% to $2.84 after the company announced plans to acquire Insight Genetics for $12 million.
  • ObsEva SA OBSV rose 6.8% to $3.79. ObsEva and Yuyuan BioScience Technology announced sublicense agreement to develop and commercialize Nolasiban in the People's Republic of China.
  • Invitae Corporation NVTA rose 6.5% to $17.80. Invitae said it generated revenue of $216 million in 2019, up more than 45% versus the $147.7 million in 2018.
  • At Home Group Inc. HOME rose 6.5% to $5.42 after the company raised Q4 and FY20 EPS guidance above analyst estimates.
  • Amarin Corporation plc AMRN rose 6.5% to $20.18. Amarin reported the launche of True To Your Heart, a campaign to educate people on persistent cardiovascular risk.
  • Jumei International Holding Limited JMEI shares rose 5.9% to $18.73 after falling 5.78% on Friday.

 

Check out these big penny stock gainers and losers

Losers

  • Acasti Pharma Inc ACST shares dipped 73.2% to $0.58 after the company announced its TRILOGY 1 Phase 3 trial of CaPre did not reach statistical significance.
  • Stage Stores, Inc. SSI fell 55.5% to $3.24 after the company reported a 1.4% year-over-year rise in its holiday same-store sales. The company announced it expects full-year 2019 earnings to be $25 million to $30 million below the low end of the previously announced guidance range.
  • Aquestive Therapeutics Inc AQST dropped 29.2% to $4.68. Aquestive Therapeutics received FDA response denying Aquestive's Citizen's petition received by the FDA on November 1, 2019.
  • Ameri Holdings Inc AMRH dipped 24% to $1.85 after the company announced it plans to merge with Jay Pharma.
  • Tilly's Inc TLYS dropped 21% to $9.20 after the company reported a 2% drop in holiday same-store sales and issued weak Q4 earnings forecast.
  • Inogen Inc INGN fell 20.7% to $48.53 after the company issued weak sales forecast.
  • ABIOMED, Inc. ABMD dipped 16% to $158.71 after the company issued Q3 and FY20 sales guidance below analyst estimates.
  • Cyclacel Pharmaceuticals Inc CYCC fell 16% to $0.76 after the company announced it received a notice of delisting or failure to satisfy a continued listing rule or standard.
  • Five Below Inc FIVE dropped 15% to $102.92 after the company issued preliminary Q4 & FY20 EPS and sales guidance below analyst estimates.
  • Cassava Sciences Inc SAVA dropped 13.5% to $7.05.
  • SemiLEDs Corporation LEDS dropped 13.5% to $2.11.
  • Salarius Pharmaceuticals Inc SLRX dipped 12.4% to $3.31.
  • Magenta Therapeutics Inc MGTA shares fell 12.3% to $13.37.
  • Carrols Restaurant Group Inc TAST fell 11.6% to $6.00.
  • EXACT Sciences Corporation EXAS dropped 11.3% to $92.62 despite the company's upbeat Q4 and FY19 sales guidance issued on Sunday.
  • AxoGen, Inc AXGN fell 10.9% to $14.17 after the company issued FY20 sales forecast.
  • BioNTech SE – ADR BNTX dipped 10.5% to $35.52. Iovance Biotherapeutics and Cellectis entered into a research collaboration and exclusive worldwide license agreement.
  • Iovance Biotherapeutics Inc IOVA dropped 10.3% to $24.35.
  • Cyclerion Therapeutics, Inc. CYCN fell 9.7% to $3.08.
Loading...
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...